heres a little offtake from an article in regards to pre IND meetings with the FDAThe pre-IND meeting typically includes a discussion of scientific and regulatory aspects of the drug as they relate to safety and/or potential clinical hold issues. Sponsors are strongly encouraged to take advantage of the pre-IND meeting for the following reasons:
https://www.nuventra.com/resources/blog/fda-pre-ind-meeting-guide/
- -The information gained from the meeting can help ensure a complete IND application is submitted and potentially help avoid clinical holds
- -The meeting presents a formal opportunity to gather the FDA’s perspectives, recommendations, and preliminary agreement (or disagreement) on critical aspects of your development program
- -The meeting is an opportunity to build a constructive relationship with the FDA
- -No fees are required for this meeting
- source
- Forums
- ASX - By Stock
- OCC
- Ann: Notice under Section 708(A) of the Corporations Act
Ann: Notice under Section 708(A) of the Corporations Act, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
(20min delay)
|
|||||
Last
40.0¢ |
Change
0.010(2.56%) |
Mkt cap ! $83.83M |
Open | High | Low | Value | Volume |
39.0¢ | 40.0¢ | 39.0¢ | $199.1K | 504.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3807 | 39.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 3666 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2599 | 0.385 |
3 | 27634 | 0.380 |
2 | 42700 | 0.375 |
4 | 23903 | 0.370 |
5 | 42071 | 0.365 |
Price($) | Vol. | No. |
---|---|---|
0.400 | 3666 | 2 |
0.405 | 74300 | 2 |
0.410 | 45237 | 4 |
0.420 | 135239 | 3 |
0.425 | 39350 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |